Concepedia

PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2

Sergio Dalla‐Volta, Antonio Palla, Annamaria Santolicandro, Carlo Giuntini, Vittorio Pengo, O Visioli, Pietro Zonzin, D Zanuttini, F Barbaresi, Giancarlo Agnelli,

Journal of the American College of Cardiology · 1992 · 375 citations · 16 references

DOI

Concepts

References

16

Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

R B Sleight, Peter Sleight, Sarah Parish et al. · PubMed · 1988 · 2.9K citations

, , +9

ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction

The Lancet · 1992 · 922 citations

, , +16

MEDICAL SCIENCE GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction

GRUPPOITALIANOPERLOSTUDIODELL · The Lancet · 1990 · 911 citations

, , +14

ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION

D Hunt, George Varigos, F Dienstl et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1992 · 898 citations

, , +12

Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism.

M Verstraete, Graham Miller, Henri Bounameaux et al. · Circulation · 1988 · 407 citations

, , +11